4//SEC Filing
Kane William P Jr 4
Accession 0001104659-21-107405
CIK 0001720893other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:25 PM ET
Size
14.5 KB
Accession
0001104659-21-107405
Insider Transaction Report
Form 4
Kane William P Jr
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-16+40,000→ 40,000 totalExercise: $23.84Exp: 2031-08-16→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of August 16, 2021 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person'scontinuous employment with the Issuer through the relevant vesting dates.
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001813937
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:25 PM ET
- Size
- 14.5 KB